Acadian Asset Management »

Monte Rosa Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $586k 111k 5.29
2024-06-30 $366k 99k 3.71
2024-03-31 $390k 56k 7.02